Product Images Glyburide And Metformin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Glyburide And Metformin Hydrochloride NDC 65862-082 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1.25 mg/250 mg (100 Tablets Bottle) - glymet fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1.25 mg/250 mg (100 Tablets Bottle) - glymet fig1

This is a prescription medication containing 55mg/250mg of glyburide USP and metformin hydrochloride USP. The recommended dosage information can be found on the package insert. It is advised to store the medication at 20°C to 25°C (68°F to 77°F) with permitted temperature excursions ranging from 15°C to 30°C (59°F to 86°F). The container consists of 100 tablets with child-resistant closures and is light-resistant. The medication distributed by Aurobindo Pharma USA, Inc. and manufactured in India. The code is TS/DRUGS9/1993. Not available.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg/500 mg (100 Tablets Bottle) - glymet fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg/500 mg (100 Tablets Bottle) - glymet fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg/500 mg (100 Tablets Bottle) - glymet fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg/500 mg (100 Tablets Bottle) - glymet fig3

Glyburide Chemical Structure - glymet str1

Glyburide Chemical Structure - glymet str1

Metformin Hydrochloride Chemical Structure - glymet str2

Metformin Hydrochloride Chemical Structure - glymet str2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.